CT-Plaque Vulnerability Index (Low-Attenuation Plaque %) Calculator
Plaque Volume Assessment
Enter CCTA plaque measurements. Use vessel volume or a validated direct LAP-burden measurement for comparison with the SCOT-HEART threshold.
| Parameter | Value | Notes |
|---|
The hazard ratio estimate is a population-level association from a stable-chest-pain cohort, not an individual absolute-risk prediction or treatment recommendation.
Clinical Context and Calculation
Low-attenuation non-calcified plaque on coronary CT angiography is associated with subsequent myocardial infarction. In the SCOT-HEART analysis, LAP was defined using an attenuation threshold below 30 Hounsfield units (HU), and quantitative plaque burden was calculated relative to the vessel volume of the assessed region.
Calculations used
- LAP as a proportion of total plaque (%) = LAP volume ÷ total plaque volume × 100.
- Vessel-volume LAP burden (%) = LAP volume ÷ assessed vessel volume × 100.
- Research relative HR vs. 1% burden = 1.60log2(burden / 1%), shown only when a vessel-volume-based or directly entered burden is available and positive.
Interpretation and limitations
In the SCOT-HEART cohort, LAP burden >4% was associated with a higher subsequent MI risk (HR 4.65; 95% CI 2.06–10.5), while each doubling of LAP burden was associated with an adjusted HR of 1.60 (95% CI 1.10–2.34). These estimates were derived in patients presenting with stable chest pain and should not be interpreted as a patient-specific probability of MI.
Quantification depends on CCTA acquisition, image quality, segmentation, software, and the exact region assessed. The calculator does not independently segment images or validate measurements. Use the analysis method and denominator defined by the source study/software when comparing values.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.